Status and phase
Conditions
Treatments
About
The aim of the trial is to study the efficacy of adding concomitant chemotherapy (carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
406 participants in 2 patient groups
There are currently no registered sites for this trial.
Start date
Feb 15, 2008 • 16 years ago
End date
Mar 26, 2018 • 6 years ago
Today
Jan 22, 2025
Lead Sponsor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal